CombinedX (CX) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
19 Aug, 2026Executive summary
Revenue grew 30.6% year-over-year to 251.2 MSEK in Q2 2024, with organic growth of 2.1%, mainly driven by acquisitions.
Adjusted EBIT margin nearly halved to 5.6% from 10.1% year-over-year, reflecting lower profitability.
Growth was driven by acquisitions, but profitability was impacted by market challenges, lower utilization rates, and integration costs.
Cost-saving measures and new contracts are expected to improve performance later in 2024.
Financial highlights
Q2 net sales: 251.2 MSEK (192.4), Adjusted EBIT: 13.9 MSEK (19.4), Adjusted EBIT margin: 5.6% (10.1%).
Calendar-adjusted growth was 28.9%, with organic growth at 0.9%.
LTM revenue reached 840.2 MSEK, with LTM adjusted EBIT margin at 8.8%.
Intäkter per FTE increased 3.2% to 1,672 KSEK/year LTM; personnel cost per FTE up 7.3% to 1,034 KSEK/year.
Cash position at quarter-end was 94.0 MSEK; net debt/EBITDA at 0.4x.
Outlook and guidance
Management expects profitability to recover as cost-saving measures and integration synergies take effect later in the year.
No formal forecasts provided, but future prospects are considered good.
Signs of improving demand in the market, but too early to confirm a sustained upturn.
Latest events from CombinedX
- Adjusted EBITA margin fell to 4.6% as Nethouse divestment boosted liquidity and equity.CX
Q2 2026 - Q1 2026 saw 8.2% revenue growth, record margins, and a major divestment reshaping the group.CX
Q1 2026 - Record revenue, margin gains, and acquisitions drive a strategic shift to specialist brands.CX
Q4 2025 - Q3 2025 saw higher margins and revenue, driven by acquisitions despite negative organic growth.CX
Q3 2025 - Revenue declined and margins improved, with acquisitions supporting strategic growth.CX
Q2 2025 - Sales up 27.5% but margins and organic growth fell; restructuring targets improved 2025 results.CX
Q3 2024 - Q1 2025 saw 6.5% revenue growth and resilient margins despite market challenges.CX
Q1 2025 - Revenue surged but organic growth and margins fell; acquisitions set up 2025 recovery.CX
Q4 2024